What are the evidence‑based benefits of incentive spirometry for preventing postoperative atelectasis and pneumonia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Evidence-Based Benefits of Incentive Spirometry

Primary Recommendation

Incentive spirometry alone provides no proven benefit over deep breathing exercises for preventing postoperative pulmonary complications, but when combined with multimodal respiratory care (deep breathing, early mobilization, supported coughing, adequate analgesia), it reduces atelectasis and pneumonia in high-risk surgical patients. 1, 2, 3

Demonstrated Benefits in High-Risk Populations

Reduction in Pulmonary Complications

  • Incentive spirometry as part of multimodal care reduces postoperative pneumonia risk by approximately 55-56% (risk ratio 0.44-0.45) in patients undergoing abdominal surgery 1

  • Atelectasis rates decrease by 41-47% (risk ratio 0.53-0.59) when incentive spirometry is combined with comprehensive respiratory physiotherapy 1, 3

  • In cardiac surgery patients receiving preoperative inspiratory muscle training with incentive spirometry devices, overall respiratory complications decreased from 27.3% to 10.2%, though pneumonia reduction (7.1% vs 3.1%) did not reach statistical significance in shorter protocols 1

Hospital Length of Stay

  • Hospital stay is reduced by 1-3.2 days when incentive spirometry is part of multimodal prehabilitation and postoperative care programs 1

  • The benefit is most pronounced when respiratory preparation includes at least 2-4 weeks of preoperative training with inspiratory pressure devices 1, 2

Patient Populations That Benefit Most

High-Risk Criteria (Strong Evidence)

  • Age >60 years - the strongest patient-related risk factor for postoperative pulmonary complications 1, 3

  • Chronic obstructive pulmonary disease - emerging evidence shows specific benefit in COPD patients when incentive spirometry is combined with smoking cessation, early mobilization, and effective analgesia 2, 4

  • ASA class II or higher, functional dependence, congestive heart failure 1, 3

  • Low serum albumin <35 g/L - one of the most powerful predictors of complications 1, 3, 5

High-Risk Surgical Procedures

  • Abdominal surgery (especially upper abdominal), thoracic surgery, head and neck surgery, vascular surgery, neurosurgery 1, 5

  • Prolonged surgery >3-4 hours (odds ratio 2.14) 3, 5

  • Emergency surgery (odds ratio 4.47) 3, 5

Optimal Implementation Protocol

Technique and Frequency

  • Perform 10 maximal inspiratory maneuvers every hour while awake, continuing for at least 2-4 weeks postoperatively 2

  • Patients must sit upright when using the device, taking slow deep breaths through the mouthpiece, holding for 3-5 seconds, then exhaling 2

  • Volume-oriented devices are preferred over flow-oriented devices 6

Essential Multimodal Components (Cannot Be Omitted)

  • Deep breathing exercises - provide equivalent benefit to incentive spirometry alone and are more labor-efficient 1, 2, 3

  • Early mobilization - patients should be out of bed on the day of surgery 2, 3

  • Supported coughing with incision splinting 3

  • Adequate pain control - essential to prevent ineffective use 2, 3

  • Selective (not routine) nasogastric tube use - routine placement significantly increases pneumonia and atelectasis rates 1, 3

When Incentive Spirometry Provides NO Additional Benefit

Cardiac Surgery Population

  • A 2012 Cochrane review of 592 CABG patients found no evidence of benefit from incentive spirometry compared to physical therapy alone, positive pressure breathing, or preoperative education 7

  • Adding incentive spirometry to comprehensive physiotherapy does not improve outcomes compared to multimodal care alone in coronary surgery patients 8, 7

  • Routine use after CABG is not recommended 6

General Thoracic Surgery

  • No demonstrated benefit in reducing postoperative pulmonary complications or hospital stay when added to standard thoracic expansion exercises, supported coughing, and early mobilization 2, 4

  • Exception: Higher-risk thoracic surgery patients with COPD may benefit when incentive spirometry is part of multimodal care 4

Superior Alternatives for Specific Situations

Hypoxemic Patients Unable to Perform Incentive Spirometry

  • CPAP or non-invasive positive pressure ventilation at 8-10 cm H₂O for 8-12 hours post-extubation is superior to standard oxygen therapy and incentive spirometry 2, 3

  • CPAP of 10 cm H₂O after thoracoabdominal surgery reduces ICU and hospital stay more effectively than incentive spirometry alone 5

Patients with Inadequate Effort or Adherence

  • Nasal continuous positive-airway pressure may be especially beneficial when patients cannot perform incentive spirometry or deep breathing exercises effectively 1

Critical Pitfalls to Avoid

  • Never use incentive spirometry as a standalone intervention - it must be part of multimodal care including deep breathing, mobilization, and adequate analgesia 2, 3, 6

  • Do not apply to low-risk patients - no evidence of benefit and wastes resources 2

  • Avoid routine nasogastric tube placement - selective use significantly reduces pneumonia compared to routine placement 1, 3

  • Do not delay early mobilization - mobilization is equally or more important than incentive spirometry 2, 3

  • Inadequate pain control renders incentive spirometry ineffective - optimize analgesia first 2, 3

  • Patient adherence is challenging - studies show difficulty achieving prescribed frequency, limiting real-world effectiveness 4, 8

Preoperative Optimization

  • Cardiorespiratory and muscular prehabilitation programs of at least 4 weeks preoperatively reduce postoperative complications (OR 0.52) and severe pneumonia (OR 0.40) 1

  • Inspiratory muscle training with adjustable pressure valve devices requires minimum 5 days of twice-daily practice, though 2-4 weeks is optimal 1, 2

  • Smoking cessation 4-8 weeks preoperatively is essential for COPD patients as part of multimodal care 2, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Incentive Spirometry in Postoperative Care

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Post-Operative Pulmonary Hygiene Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Prevention and Management of Postoperative Atelectasis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Incentive spirometry: 2011.

Respiratory care, 2011

Related Questions

Is incentive spirometry (IS) beneficial for patients after a surgical procedure?
What is the best approach to improve lung function in patients with respiratory conditions or recent surgical intervention using incentive spirometry (IS)
What are the contraindications for incentive spirometry (IS)
What is the role of incentive spirometry (IS) in patients with a history of respiratory disease, cancer, or other conditions that may impact lung function after undergoing thoracentesis?
What is the role and indication of incentive spirometry (IS) in patients at risk of pulmonary complications?
What is the appropriate dose, duration, and precautions for using Bactrim (trimethoprim‑sulfamethoxazole) to treat an uncomplicated urinary tract infection in a child?
What is the weight‑based single dose of trimethoprim‑sulfamethoxazole (Bactrim) for a child?
In an adult without severe respiratory disease, uncontrolled hypertension, renal or hepatic impairment, peptic ulcer disease, or drug allergies, can hydrocodone, pregabalin, amitriptyline, and meloxicam be used together?
In a patient with ongoing malnutrition after several days of therapy, what emergency department interventions should be initiated to stabilize nutrition, correct electrolyte and vitamin deficiencies, and begin a safe re‑feeding regimen?
In a 73‑year‑old post‑menopausal woman with cancer antigen 125 (CA‑125) 6 U/mL, carcinoembryonic antigen (CEA) 4.9 ng/mL, alpha‑fetoprotein (AFP) 4.2 ng/mL, estradiol 3300 pg/mL, follicle‑stimulating hormone (FSH) 3.7 IU/L, luteinizing hormone (LH) 1.1 IU/L, prolactin 16.1 ng/mL and total cortisol 2.8 µg/dL, what is the most likely diagnosis?
When should the hCG or GnRH‑agonist trigger be omitted before intra‑uterine insemination in patients with high estradiol (>3500 pg/mL), numerous follicles (≥12 ≥10 mm or ≥4 ≥16 mm), polycystic ovary syndrome, a positive pregnancy test, uncontrolled thyroid disease, severe hypertension, active pelvic infection, severe endometriosis, recent ovarian surgery, hypersensitivity to the trigger, anticoagulation, significant cardiac disease, or any other contraindication to pregnancy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.